We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search

Refine your search

89 results found

Article

Carpmaels & Ransford LLP | United Kingdom, European Union | 8 Aug 2018

UKIPO helps to clarify the future UK-EU relationship on intellectual property

The UK Intellectual Property Office has published an update to its page “IP and BREXIT: The facts”. Although by no means a detailed legal proposal

Article

Carpmaels & Ransford LLP | United Kingdom | 25 Apr 2018

Claiming costs and expenses in High Court litigation as licensee

While there are many good reasons for recording a patent licence and keeping an up-to-date register, a recent High Court ruling illustrates the

Article

Carpmaels & Ransford LLP | United Kingdom, European Union | 18 Apr 2018

IP rights - what does the future hold after Brexit?

The European Commission recently published its draft withdrawal agreement setting out its proposals for the arrangements surrounding the United

Article

Carpmaels & Ransford LLP | European Union | 21 Mar 2018

Clarification of disclaimer practice at the EPO

In its recent G 116 decision, the European Patent Office (EPO) Enlarged Board of Appeal clarified how disclaimers should be examined. While

Article

Carpmaels & Ransford LLP | United Kingdom, European Union | 13 Dec 2017

Progress for the UPC Agreement

The UK parliament has moved closer to ratification of the Unified Patent Court (UPC) Agreement with parliament’s approval of the remaining UK

Article

Carpmaels & Ransford LLP | United Kingdom, European Union | 7 Dec 2017

SPCs: clarity on claims with functional features?

The German Federal Patent Court has asked the CJEU how its “implicitly, but necessarily and specifically” test for assessing Article 3(a) of

Article

Carpmaels & Ransford LLP | United Kingdom | 29 Nov 2017

Unregistered IP rights may have significant consequences for interested parties

Registered IP rights can be highly valuable assets, but their creation, development, exploitation and acquisition require significant time, effort and

Article

Carpmaels & Ransford LLP | United Kingdom | 24 Nov 2017

Actavis v ICOS

ICOS’s patent EP 1173181 is directed to a dosage regimen of the phosphodiesterase type 5 (PDE5) inhibitor tadalafil, which is marketed by Lilly under

Article

Carpmaels & Ransford LLP | European Union, Germany | 22 Nov 2017

New referral regarding SPC availability for certain medical devices

A new question has been referred to the European Court of Justice by the German Federal Patent Court on the availability of supplementary protection

Article

Carpmaels & Ransford LLP | United Kingdom, European Union | 16 Nov 2017

Reasons for recordal 1, 2, 3

Failure to register intellectual property rights (IPRs) can lead to significant consequences for the interested parties Registered IPRs can be highly

Previous page 1 2 3 ...